Financial Statements — GLSI
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 10.51 | 3.81 | 3.13 | 2.75 | 5.82 | 7.22 | 5.51 | 9.14 | 10.94 | 11.91 | 15.64 | 17.19 | 19.74 | 28.91 | 29.80 | 30.40 |
| Total Current Assets | 10.51 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 28.91 | 29.80 | 30.40 |
| Intangible Assets | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Total Non-current Assets* | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.01 | 0.01 | 0.02 |
| Total Assets | 10.51 | 3.81 | 3.13 | 2.75 | 5.83 | 7.23 | 5.51 | 9.15 | 10.95 | 11.92 | 15.65 | 17.20 | 19.75 | 28.92 | 29.82 | 30.42 |
| Accounts Payable | 4.51 | 1.11 | 1.30 | 1.05 | 0.77 | 1.34 | 0.35 | 0.23 | 0.30 | 0.22 | 0.22 | 0.22 | 0.22 | 0.30 | 0.63 | 0.61 |
| Total Current Liabilities | 5.24 | 1.62 | 1.69 | 1.44 | 0.84 | 1.35 | 0.39 | 0.30 | 0.30 | 0.24 | 0.24 | 0.23 | 0.24 | 0.46 | 0.65 | 0.67 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.24 | 1.62 | 1.69 | 1.44 | 0.84 | 1.35 | 0.39 | 0.30 | 0.30 | 0.24 | 0.24 | 0.23 | 0.24 | 0.46 | 0.65 | 0.67 |
| Retained Earnings | (92.79) | (77.59) | (73.44) | (69.41) | (58.11) | (55.44) | (52.84) | (47.62) | (45.23) | (43.60) | (38.68) | (36.36) | (35.62) | (31.29) | (30.42) | (29.67) |
| Total Stockholder Equity | 5.27 | 2.18 | 1.44 | 1.31 | 4.98 | 5.88 | 5.12 | 8.85 | 10.65 | 11.68 | 15.41 | 16.97 | 19.51 | 28.46 | 29.16 | 29.75 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Research & Development | 5.21 | 7.59 | 3.52 | 3.51 | 2.60 | 6.16 | 2.29 | 2.31 | 2.19 | 2.33 | 2.16 | 1.38 | 1.83 | 2.46 | 1.72 | 0.63 | 1.66 | 2.06 | 0.66 | 0.56 |
| Selling, General & Admin | 0.52 | 0.36 | 0.65 | 0.54 | 0.68 | 1.93 | 0.44 | 0.35 | 0.34 | 0.50 | 0.34 | 0.37 | 0.41 | 0.44 | 0.66 | 0.14 | 0.33 | 0.31 | 0.21 | 0.20 |
| Total Operating Expenses | 5.73 | 7.94 | 4.17 | 4.05 | 3.28 | 8.08 | 2.73 | 2.66 | 2.54 | 2.84 | 2.50 | 1.75 | 2.24 | 2.89 | 2.38 | 0.77 | 1.99 | 2.38 | 0.87 | 0.75 |
| Operating Income | (5.73) | (7.94) | (4.17) | (4.05) | (3.28) | (8.08) | (2.73) | (2.66) | (2.54) | (2.84) | (2.50) | (1.75) | (2.24) | (2.89) | (2.38) | (0.77) | (1.99) | (2.38) | (0.87) | (0.75) |
| Net Income | (5.66) | (7.92) | (4.15) | (4.03) | (3.26) | (8.04) | (2.67) | (2.61) | (2.47) | (2.75) | (2.39) | (1.63) | (2.12) | (2.79) | (2.32) | (0.75) | (1.97) | (2.36) | (0.86) | (0.75) |
| Basic EPS | (0.39) | (0.58) | (0.30) | (0.30) | (0.25) | (0.62) | (0.20) | (0.20) | (0.19) | (0.20) | (0.19) | (0.13) | (0.17) | (0.22) | (0.18) | (0.06) | (0.15) | -- | -- | -- |
| Diluted EPS | (0.39) | (0.58) | (0.30) | (0.30) | (0.25) | (0.62) | (0.20) | (0.20) | (0.19) | (0.21) | (0.19) | (0.13) | -- | -- | -- | -- | -- | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Operating Cash Flow | (4.70) | (3.17) | (2.67) | (2.23) | (1.83) | (1.85) | (2.58) | (1.05) | (1.78) | (2.15) | (1.80) | (0.97) | (1.56) | (2.17) | (1.55) | (0.53) | (1.95) | (2.26) | (0.89) | (0.60) |
| Financing Cash Flow | 9.03 | 5.55 | 3.35 | 2.61 | 0.49 | 0.12 | 1.18 | 2.77 | 0.30 | -- | -- | -- | -- | 0.00 | 0.00 | (2.02) | (5.51) | 0.56 | 0.00 | 0.00 |
